Expression of carbonic anhydrase IX is associated with postoperative recurrence and poor prognosis in surgically treated oral squamous cell carcinoma

Human Pathology

Volumn 39, Issue 9, 2008, Pages 1317-1322

  Choi, Sung Weon ^a   Kim, Joo Young ^a   Park, Joo Yong ^a   Cha, In Ho ^b   Kim, Jin ^b   Lee, Sun ^c  

^a National Cancer Center   (South Korea)

^b Yonsei University College of Dentistry   (South Korea)

^c Kyung Hee University Hospital   (South Korea)

Author keywords

CA9 protein; Mouth neoplasms; Prognosis

Indexed keywords

CARBONATE DEHYDRATASE IX; ENZYME ANTIBODY;

ADULT; AGED; ARTICLE; CANCER CELL; CANCER PATIENT; CANCER SURGERY; CANCER SURVIVAL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MALE; MOUTH CARCINOMA; ORAL SURGERY; OVERALL SURVIVAL; POSTOPERATIVE PERIOD; PROGNOSIS; PROTEIN EXPRESSION; RECURRENT CANCER; SEX DIFFERENCE; SMOKING; SQUAMOUS CELL CARCINOMA; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

ANTIGENS, NEOPLASM; CARBONIC ANHYDRASES; CARCINOMA, SQUAMOUS CELL; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS;

EID: 48949096355     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2007.10.026     Document Type: Article

References (24)

1. Parken D.M., Laara E., and Muir C.S. Estimates of the worldwide frequency of sixteen major cancers in 1980. Int J Cancer 41 (1988) 184-197
2. Day G.L., and Blot W.J. Second primary tumors in patients with oral cancer. Cancer 70 (1992) 14-19
3. Carvalho A.L., Nishimoto I.N., Califano J.A., and Kowalski L.P. Trends in incidence and prognosis for head and neck cancer in the United States: a site-specific analysis of the SEER database. Int J Cancer 114 (2004) 806-816
4. Szelachowska J., Dziegiel P., Jelen-Krzeszewska J., et al. Mcm-2 protein expression predicts prognosis better than Ki-67 antigen in oral cavity squamocellular carcinoma. Anticancer Res 26 (2006) 2473-2478
5. LoMuzio L., Santarelli A., Caltabiano R., et al. p64 overexpression associates with poor prognosis in head and neck squamous cell carcinoma. Hum Pathol 36 (2005) 187-194
6. Vaupel P., Kallinowski F., and Okunieff P. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res 49 (1989) 6449
7. Towle H.C. Metabolic regulation of gene transcription in mammals. J Biol Chem 270 (1995) 23235-23238
8. Harris A.L. Hypoxia-a key regulatory factor in tumour growth. Nat Rev Cancer 2 (2002) 38-47
9. Wykoff C.C., Beasley N.J.P., Watson P.H., et al. Hypoxia inducible regulation of tumor associated carbonic anhydrases. Cancer Res 60 (2001) 7075-7083
10. Opavsky R., Pastorekova S., Zelnik V., et al. Human MN/CA9 gene, a novel member of the carbonic anhydrase family: structure and exon to protein domain relationships. Genomics 33 (1996) 480-487
11. Ivanov S.V., Kuzmin I., Wei M.H., et al. Down-regulation of transmembrane carbonic anhydrases in renal cell carcinoma cell lines by wild-type von Hippel-Linday transgenes. Proc Natl Acad Sci U S A 95 (1998) 12596-12601
12. Koukourakis M.I., Giatromanolaki A., Sivridis E., et al. Hypoxia-regulated carbonic anhydrase-9 (CA9) relates to poor vascularization and resistance of squamous cell head and neck cancer to chemoradiotherapy. Clin Cancer Res 7 (2001) 3399-3403
13. Hedley D., Pintilie M., Woo J., et al. Carbonic anhydrase IX expression, hypoxia, and prognosis in patients with uterine cervical carcinomas. Clin Cancer Res 9 (2003) 5666-5674
14. Bui M.H., Seligson D., Han K.R., et al. Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapy. Clin Cancer Res 9 (2003) 802-811
15. Giatromanolaki A., Koukourakis M.I., Sivridis E., et al. Expression of hypoxia-inducible carbonic anhydrase-9 relates to angiogenic pathways and independently to poor outcome in non-small cell lung cancer. Cancer Res 61 (2001) 7992-7998
16. Supuran C.T., Scozzafava A., and Casini A. Carbonic anhydrase inhibitors. Med Res Rev 23 (2003) 146-189
17. Lee S., Shin H.J., Han I.O., et al. Tumor carbonic anhydrase 9 expression is associated with the presence of lymph node metastases in uterine cervical cancer. Cancer Sci 98 (2007) 329-333
18. Pastorek J., Pastorekova S., and Callebaut I. Cloning and characterization of MN, a human tumor-associated protein with a domain homologous to carbonic anhydrase and a putative helix-loop-helix DNA binding segment. Oncogene 9 (1994) 2877-2888
19. Brennan D.J., Jirstrom K., Kronblad A., et al. CA IX is an independent prognostic marker in premenopausal breast cancer patients with one to three positive lymph node and a putative marker of radiation resistance. Clin Cancer Res 12 (2006) 6421-6431
20. Pastoreková S., and Pastorek J. Cancer-related carbonic anhydrase isozymes and their inhibition. In: Supuran C.T., Scozzafava A., and Conway J. (Eds). Carbonic anhydrase-its inhibitors and activators (2004), CRC Press, Boca Raton, FL 255-281
21. Supuran C.T., Scozzafava A., and Casini A. Development of sulfonamide carbonic anhydrase inhibitors. In: Supuran C.T., Scozzafava A., and Conway J. (Eds). Carbonic anhydrases-its inhibitors and activators (2004), CRC Press, Boca Raton, FL 67-147
22. Casini A., Antel J., Abbate F., et al. Carbonic anhydrase inhibitors: SAR and x-ray crystallographic study for the interaction of sugar sulfamatest/sulfamides with iso enzymes I, II and IV. Bioorg Med Chem Lett 13 (2003) 841-845
23. Vullo D., Innocenti A., Nishimori I., et al. Carbonic anhydrase inhibitors. Inhibition of the transmembrane isozyme XII with sulfonamides-a new target for the design of antitumor and antiglaucoma drugs?. Bioorg Med Chem Lett 15 (2005) 963-969
24. Supuran C.T., Briganti F., Tilli S., Chegwidden W.R., and Scozzafava A. Carbonic anhydrase inhibitors: sulfonamides as antitumor agents?. Bioorg Med Chem 9 (2001) 703-714